Efficacy of Polynucleotide-Based Therapy in Atopic Dermatitis Management

Area of Science:

• Dermatology
• Regenerative Medicine

Background:

• Atopic dermatitis (AD) is a chronic inflammatory skin condition impacting quality of life.
• Current treatments aim for anti-inflammatory effects and improved skin hydration.

Purpose of the Study:

• To assess the clinical effectiveness, patient satisfaction, and safety of polynucleotide (PN) injectable therapies for atopic dermatitis.

Main Methods:

• Intradermal PN injections were administered to patients diagnosed with AD.
• Outcomes measured included clinical photography, skin hydration, erythema, thickness, and patient-reported itching and discomfort.

Main Results:

• Significant improvements observed in erythema, skin hydration, and elasticity.
• Patients reported reduced itching and discomfort, with high satisfaction and adherence.
• No significant adverse events were reported during the study.

Conclusions:

• PN-based injectable therapies may benefit AD patients by enhancing skin hydration and barrier function.
• Preliminary findings suggest symptomatic relief, but further controlled studies are essential.
• Larger, prospective studies are needed to validate efficacy, safety, and optimal dosing for AD treatment.